0 NASDAQ Companies - October 22, 2019Akcea Therapeutics to Hold Third Quarter 2019 Financial Results WebcastBOSTON, Oct. 22, 2019 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today that […]Read More
0 TSX News - October 22, 2019Aptose To Release Third Quarter Ended September 30, 2019 Financial Results and Hold Conference Call on November 5, 2019SAN DIEGO and TORONTO, Oct. 22, 2019 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology […]Read More
0 NASDAQ Companies - October 22, 2019Steve Madden Announces Third Quarter 2019 Earnings Conference CallLONG ISLAND CITY, N.Y., Oct. 22, 2019 (GLOBE NEWSWIRE) — Steven Madden, Ltd. (NASDAQ: SHOO), a leading designer and marketer […]Read More
0 NASDAQ Companies - October 22, 2019CTG Reports 2019 Third Quarter Results; Operating Income Nearly Doubles on Year-over-Year Revenue Increase of 8%Revenue Increased 7.7% Year-over-Year and 11.0% Year-to-DateSolutions Business Increased 13.9% Year-over-Year to 33.9% of Total RevenueGAAP EPS of $0.06; non-GAAP […]Read More
0 NYSE Companies - October 22, 2019TransUnion Announces Strong Third Quarter 2019 ResultsCHICAGO, Oct. 22, 2019 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) (the “Company”) today announced financial results for the quarter ended […]Read More
0 NYSE Companies - October 22, 2019Comstock Mining Announces Notice of Third Quarter 2019 Results and Business Update Conference CallVIRGINIA CITY, Nev., Oct. 22, 2019 (GLOBE NEWSWIRE) — Comstock Mining Inc. (the “Company”) (NYSE American: LODE) will host a […]Read More
0 NASDAQ Companies - October 22, 2019U.S. Well Services Announces Third Quarter 2019 Earnings Release Date and Conference CallHOUSTON, Oct. 22, 2019 (GLOBE NEWSWIRE) — U.S. Well Services, Inc. (NASDAQ: USWS) will host its third quarter 2019 earnings […]Read More
0 NASDAQ Companies - October 22, 2019Biogen Plans Regulatory Filing for Aducanumab in Alzheimer’s Disease Based on New Analysis of Larger Dataset from Phase 3 StudiesNew analysis of larger dataset showed that aducanumab reduced clinical decline in patients with early Alzheimer’s disease as measured by […]Read More
0 NYSE Companies - October 22, 2019AAC Holdings Finalizing Agreement with Lenders and Finalizing Appointment of New Independent Board MembersBRENTWOOD, Tenn., Oct. 22, 2019 (GLOBE NEWSWIRE) — AAC Holdings, Inc. (NYSE: AAC) today announced that as a result of […]Read More
0 NASDAQ Companies - October 22, 2019TLC Reports Third Quarter 2019 Financial Results and Provides Business UpdateSOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 22, 2019 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage […]Read More